Indeed, MIC expression has been described as an indicator of better prognosis in CRC patients [39], and the release of NKG2D ligands from tumor cells has been previously demonstrated as a novel cancer immunoevasion mechanism [40], [41]. The gene discussed is KLRK1; the disease is neoplasm.